Skip to main content
logo
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
92.73
-5.34 (-5.45%)
At close: Feb 27, 2026, 4:00 PM EST
92.66
-0.07 (-0.08%)
After-hours: Feb 27, 2026, 7:32 PM EST

Rhythm Pharmaceuticals Revenue

In the year 2025, Rhythm Pharmaceuticals had annual revenue of $189.76M with 45.83% growth. Rhythm Pharmaceuticals had revenue of $57.25M in the quarter ending December 31, 2025, with 36.87% growth.

Revenue (ttm)
$189.76M
Revenue Growth
+45.83%
P/S Ratio
32.84
Revenue / Employee
$670,519
Employees
283
Market Cap
6.23B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025189.76M59.63M45.83%
Dec 31, 2024130.13M52.70M68.06%
Dec 31, 202377.43M53.79M227.56%
Dec 31, 202223.64M20.48M649.46%
Dec 31, 20213.15M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics1.73B
Caris Life Sciences812.03M
Mirum Pharmaceuticals521.31M
Protagonist Therapeutics46.02M
Kymera Therapeutics39.21M
Arcellx22.29M
CRISPR Therapeutics AG3.51M
Revenue Rankings

RYTM News

More News